Kate Woodhead RGN DMS provides an insight into the highlights from the Infection 360 conference. High on the agenda was the threat posed by antimicrobial resistance, with a major focus on MRSA.
Infection 360 conference saw the delegates enjoy two days of presentations from a wide range of experts, in early November in Manchester. The first day focused on antimicrobial stewardship and some of the challenging infections affecting patients both in primary and secondary care.
Antimicrobial resistance (AMR) has been identified as one of the most pressing global challenges we face in this era. The World Health Organization has identified AMR as one of the top ten global health threats. In 2019 there were 4.95 million deaths associated with bacterial AMR across 204 countries and 1.27 million of those were directly attributable. In 2022, 52,224 people had an antibiotic resistant infection, a rise of 4%, deaths due to severe antibiotic resistant infections also increased from 2021 to 2022.1
It is widely recognised that, in order to tackle antimicrobial resistance, we need to take specific actions to reduce our reliance on antibiotics or they will become less and less useful in the fight against infections. Many antibiotics currently in use are already resistant to a range of micro-organisms. It is identified that what is required to tackle resistance is:
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
